BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37402170)

  • 1. Breast cancer PDxO cultures for drug discovery and functional precision oncology.
    Scherer SD; Zhao L; Butterfield AJ; Yang CH; Cortes-Sanchez E; Guillen KP; Welm BE; Welm AL
    STAR Protoc; 2023 Sep; 4(3):102402. PubMed ID: 37402170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology.
    Guillen KP; Fujita M; Butterfield AJ; Scherer SD; Bailey MH; Chu Z; DeRose YS; Zhao L; Cortes-Sanchez E; Yang CH; Toner J; Wang G; Qiao Y; Huang X; Greenland JA; Vahrenkamp JM; Lum DH; Factor RE; Nelson EW; Matsen CB; Poretta JM; Rosenthal R; Beck AC; Buys SS; Vaklavas C; Ward JH; Jensen RL; Jones KB; Li Z; Oesterreich S; Dobrolecki LE; Pathi SS; Woo XY; Berrett KC; Wadsworth ME; Chuang JH; Lewis MT; Marth GT; Gertz J; Varley KE; Welm BE; Welm AL
    Nat Cancer; 2022 Feb; 3(2):232-250. PubMed ID: 35221336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology.
    Xu X; Kumari R; Zhou J; Chen J; Mao B; Wang J; Zheng M; Tu X; An X; Chen X; Zhang L; Tian X; Wang H; Dong X; Bao Z; Guo S; Ouyang X; Shang L; Wang F; Yan X; Zhang R; Vries RGJ; Clevers H; Li QX
    PLoS One; 2023; 18(1):e0279821. PubMed ID: 36602988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational and Clinical Relevance of PDX-Derived Organoid Models in Oncology Drug Discovery and Development.
    Kumari R; Xu X; Li HQ
    Curr Protoc; 2022 Jul; 2(7):e431. PubMed ID: 35789132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenografting.
    Aizawa Y; Takada K; Aoyama J; Sano D; Yamanaka S; Seki M; Kuze Y; Ramilowski JA; Okuda R; Ueno Y; Nojima Y; Inayama Y; Hatakeyama H; Hatano T; Takahashi H; Nishimura G; Fujii S; Suzuki Y; Taniguchi H; Oridate N
    Cell Oncol (Dordr); 2023 Apr; 46(2):409-421. PubMed ID: 36538240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research.
    Xu X; Shang L; Wang P; Zhou J; Ouyang X; Zheng M; Mao B; Zhang L; Chen B; Wang J; Chen J; Qian W; Guo S; Huang Y; Li QX
    J Vis Exp; 2021 May; (171):. PubMed ID: 34028430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of glioblastoma patient-derived organoids and mouse brain orthotopic xenografts for drug screening.
    Gamboa CM; Jara K; Pamarthy S; Liu L; Aiken R; Xiong Z; Danish S; Sabaawy HE
    STAR Protoc; 2021 Mar; 2(1):100345. PubMed ID: 33665625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
    Philp LK
    Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation.
    Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR
    Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput drug screening of fine-needle aspiration-derived cancer organoids.
    Bergdorf K; Phifer C; Bharti V; Westover D; Bauer J; Vilgelm A; Lee E; Weiss V
    STAR Protoc; 2020 Dec; 1(3):100212. PubMed ID: 33377106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Derived Xenografts and Organoids Recapitulate Castration-Resistant Prostate Cancer with Sustained Androgen Receptor Signaling.
    Van Hemelryk A; Tomljanovic I; de Ridder CMA; Stuurman DC; Teubel WJ; Erkens-Schulze S; Verhoef EI; Remmers S; Mahes AJ; van Leenders GJLH; van Royen ME; van de Werken HJG; Grudniewska M; Jenster GW; van Weerden WM
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.
    Chew NJ; Lim Kam Sian TCC; Nguyen EV; Shin SY; Yang J; Hui MN; Deng N; McLean CA; Welm AL; Lim E; Gregory P; Nottle T; Lang T; Vereker M; Richardson G; Kerr G; Micati D; Jardé T; Abud HE; Lee RS; Swarbrick A; Daly RJ
    Breast Cancer Res; 2021 Aug; 23(1):82. PubMed ID: 34344433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived tumour xenografts for breast cancer drug discovery.
    Cassidy JW; Batra AS; Greenwood W; Bruna A
    Endocr Relat Cancer; 2016 Dec; 23(12):T259-T270. PubMed ID: 27702751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional genetic dropout screens and
    Paes Dias M; Rottenberg S; Jonkers J
    STAR Protoc; 2022 Mar; 3(1):101132. PubMed ID: 35146447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for derivation of organoids and patient-derived orthotopic xenografts from glioma patient tumors.
    Oudin A; Baus V; Barthelemy V; Fabian C; Klein E; Dieterle M; Wantz M; Hau AC; Dording C; Bernard A; Michelucci A; Yabo YA; Kanli G; Keunen O; Bjerkvig R; Niclou SP; Golebiewska A
    STAR Protoc; 2021 Jun; 2(2):100534. PubMed ID: 34027491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring Real-time Drug Response in Organotypic Tumor Tissue Slices.
    Nishida-Aoki N; Bondesson AJ; Gujral TS
    J Vis Exp; 2020 May; (159):. PubMed ID: 32420994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protocol for functional profiling of patient-derived organoids for precision oncology.
    Nemati N; Boeck N; Lamberti G; Lisandrelli R; Trajanoski Z
    STAR Protoc; 2024 Mar; 5(1):102887. PubMed ID: 38367233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and long-term culture of mouse mammary stem cell organoids and breast tumor organoids.
    Cui J; Guo W
    STAR Protoc; 2021 Jun; 2(2):100577. PubMed ID: 34124696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and Use of Patient-Derived Xenograft Models for Drug Testing in Head and Neck Squamous Cell Carcinoma.
    Karamboulas C; Meens J; Ailles L
    STAR Protoc; 2020 Jun; 1(1):100024. PubMed ID: 33111077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of HER2-targeted therapy on PDX and PDX-derived organoids generated from HER2-positive salivary duct carcinoma.
    Aoyama J; Nojima Y; Sano D; Hirai Y; Kijima N; Aizawa Y; Takada K; Hatano T; Takahashi H; Nishimura G; Oridate N
    Head Neck; 2023 Jul; 45(7):1801-1811. PubMed ID: 37184432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.